Lonza collaborates with Oxford Nanopore to accelerate mRNA technology
Swiss contract drug manufacturer Lonza has partnered with Oxford Nanopore to enhance the analysis of mRNA products.
Stay updated with breaking news from Bio Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Swiss contract drug manufacturer Lonza has partnered with Oxford Nanopore to enhance the analysis of mRNA products.
Synthetic biology company Asimov has launched its new LV edge packaging system, which it claims will improve the cost efficiency and reduce the supply chain risk of lentiviral production.
The global messenger ribonucleic acid (mRNA) vaccine market currently consists entirely of vaccines for COVID-19.
Biotechnology company Vergent Bioscience has revealed that VGT-309, its investigational tumor-targeted fluorescent imaging agent, is able to help surgeons see lung tumors in real time during surgical procedures.
Genetic Design and Manufacturing Corporation (GDMC) has bagged $21 million in Series A funding to accelerate its next-gen advanced genetic therapies.